More copper and gold was good news for shareholders of a junior miner Friday. Here’s some small stocks making big moves on Friday, January 17, 2020 (as of 4 pm EST):
Atico Mining Corporation (TSXV:ATY) shares rose 4% to $0.40 on Friday after the junior miner announced that it produced 16.85 million pounds of copper with 10,480 ounces of gold in concentrates for the full year 2019, exceeding most of its adjusted 2019 operational guidance. The Company added that it will continue aggressive exploration at its El Roble and La Plata properties during 2020.
As well, shares of Argonaut Gold Inc. (TSX:AR) slipped 13% to $1.68 as the gold miner said it produced a record annual 186,615 gold equivalent ounces during 2019, falling short of its 200,000 ounce guidance, and adding that it believes it could be more profitable for the Company to produce slightly less ounces in 2020 while increasing cash flow from operations.
Tetra Bio Pharma Inc. (TSXV:TBP), meanwhile, reported that Health Canada has granted two Drug Identification Numbers (DIN) for the first over-the-counter products to be marketed under its TERPACAN banner. TERPACAN is a topical formulation that will be used for the treatment of hemorrhoids. Tetra Bio Pharma stock moved up 16% to $0.65 following the announcement.
Finally, Omineca Mining and Metals Ltd. (TSXV:OMM) shares jumped 50% to $0.09 after the junior explorer announced that it has staked an additional 36,000 hectares of mineral claims at Wingdam, British Columbia, and is now holding 100% ownership of over 39,000 contiguous hectares at its Wingdam project.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.